ClearPoint Neuro, Inc. General form of registration statement for all companies including face-amount certificate companies

Stockholders' Equity (Tables)

6 Months Ended

12 Months Ended

Jun. 30, 2012

Dec. 31, 2011

	Impact to Balance Sheet								Increase in
	Before		Impact of			After			Common Shares
	Conversions		Conversions			Conversions			Outstanding

Impact on assets
Deferred costs	$	799,123	$	(799,123	)	$	-			-

Impact on liabilities and equity
Accrued interest on converted notes	$	974,311	$	(974,311	)	$	-			1,092,559
Summer 2011 Notes, net		904,397		(904,397	)		-			2,183,334
March 2010 Notes, net		4,057,500		(4,057,500	)		-			4,071,000
2011 Unit Offering Notes, net		4,367,482		(4,367,482	)		-			9,050,834
Total impact on liabilities		10,303,690		(10,303,690	)		-			16,397,727
Series A convertible preferred stock		7,965,000		(7,965,000	)		-			7,965,000
Additional paid-in capital and common stock		-		19,345,209			19,345,209			-
Accumulated deficit		-		(1,875,642	)		(1,875,642	)		-
Total impact on equity		7,965,000		9,504,567			17,469,567			7,965,000
Total impact on liabilities and equity	$	18,268,690	$	(799,123	)	$	17,469,567			24,362,727

	Shares			Weighted - Average Exercise Price
Outstanding, January 1, 2012		3,679,977		$	2.05
Granted		2,746,400			1.00
Forfeited		(315,250	)		2.16
Outstanding, June 30, 2012		6,111,127			1.57

	Options Outstanding			Options Exercisable		Range of Exercise Prices					Weighted- average Exercise price per share		Intrinsic Value (1)
Balance at January 1, 2009		599,875				$	0.88	-	$	24.00	$	3.62	$	3,742,700
Options exercisable at January 1, 2009					432,083		0.88	-		24.00		2.70		3,133,667
Options granted (2)		93,402						9.64				9.64
Options exercised		(3,333	)					3.20				3.20
Options cancelled or forfeited		(20,167	)				1.64	-		20.00		9.60
Balance at December 31, 2009		669,777					0.88	-		24.00		4.28		3,694,400
Options exercisable at December 31, 2009					483,364		0.88	-		24.00		2.78		3,424,333
Options granted (2)		3,246,450						1.80				1.80
Options cancelled or forfeited		(153,750	)				3.20	-		24.00
Outstanding at December 31, 2010		3,762,477					0.88	-		24.00		2.11		262,500
Options exercisable at December 31, 2010					433,746		0.88	-		24.00		3.03		262,500
Options cancelled or forfeited		(82,500	)				1.80	-		24.00		4.93
Outstanding at December 31, 2011		3,679,977					0.88	-		9.64		2.05		—
Options exercisable at December 31, 2011					1,501,659		0.88	-		9.64		2.15		—

	Shares		Weighted - Average Exercise Price
Outstanding, January 1, 2012		1,922,944	$	0.43
Warrants issued		4,335,704		0.80
Outstanding, June 30, 2012		6,258,648		0.69

				Weighted -
				Average
				Exercise
	Shares			Price
Warrants outstanding at January 1, 2009		828,502		$	1.74

Warrants that expired during 2009		(417,960	)		0.04

Warrants outstanding at December 31, 2009		410,542			0.42

Warrants issued during 2010		25,444			8.00

Warrants outstanding at December 31, 2010		435,986			3.74

Warrants that expired during 2011		(410,542	)		3.48

Warrants issued during 2011		2,122,500			0.29

Warrants exercised during 2011		(225,000	)		0.01

Warrants outstanding at December 31, 2011		1,922,944			0.43

				Options Outstanding						Options Exercisable
Range of Exercise Prices				Number Outstanding		Weighted - Average Remaining Contractual Life		Weighted - Average Exercise Price		Number Exercisable		Weighted - Average Exercise Price
$	0.88	-	0.96		287,500		2.33	$	0.89		287,500	$	0.89
		1.80			3,195,950		8.96		1.80		1,065,318		1.80
	3.20	-	9.64		196,527		4.75		7.74		148,841		7.13
					3,679,977		8.21		2.05		1,501,659		2.15

Nonvested Stock Options	Shares			Weighted - Average Grant Date Fair Value
Nonvested January 1, 2009		167,792		$	1.67
Granted		93,402			2.83
Forfeited/cancelled		(7,250	)		2.84
Vested		(67,531	)		1.11
Nonvested December 31, 2009		186,413			2.41

Granted		3,246,450			0.83
Forfeited		(41,667	)		1.92
Vested		(62,465	)		2.31
Nonvested December 31, 2010		3,328,731			0.88

Forfeited		(51,833	)		0.88
Vested		(1,098,580	)		0.89
Nonvested December 31, 2011		2,178,318			0.87